Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Consuming a Sugar-based Synbiotic Product Containing Bacillus Coagulans BC30™ Spores on Subclinical Inflammation, Cardiometabolic Risk, and Intestinal Function in Healthy Individuals (SUGAR-SYN BC30 Study)

NCT07806383 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT07806383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07806383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Consuming a Sugar-based Synbiotic Product Containing Bacillus Coagulans BC30™ Spores on Subclinical Inflammation, Cardiometabolic Risk, and Intestinal Function in Healthy Individuals (SUGAR-SYN BC30 Study)
Lead sponsor
Federico II University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 4, 2026
Completion date
March 1, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overweight adults